Skip to content

The effect of misoprostol on the therapeutic abortion

Randomized clinical trial Comparison of therapeutic effects and side effects of misoprostol moistened with normal saline and acetic acid in induction of therapeutic abortion in the second trimester

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013120315634N1
Enrollment
91
Registered
2014-05-03
Start date
2014-01-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medical management of second trimester induced abortion. Medical abortion

Interventions

Intervention 1: In intervention group misoprostol tablets is wetted with 3cc acetic acid 5% and then is inserted misoprostol 400 microgram vaginally followed by 200 microgram every 6 hours for max
Treatment - Drugs
Placebo
In intervention group misoprostol tablets is wetted with 3cc acetic acid 5% and then is inserted misoprostol 400 microgram vaginally followed by 200 microgram every 6 hours for maximum 48 hours.
In controlled group misoprostol is wetted with 3cc normal saline and then is inserted misoprostol 400 microgram vaginally followed by 200 microgram every 6 hours for maximum 48 hours.

Sponsors

Vice-Chancellor for Research, Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: healthy pregnant women in their second trimester of pregnancy (14-20 weeks) with closed cervix who are candidate for therapeutic abortion and agree to participate in this clinical trial. Exclusion criteria: history of more than 2 cesarean section; history of cesarean section with uterine classic or T-shape incision; previous myomectomy; allergy to prostaglandins; severe vaginal bleeding before treatment; anemia Hb less than 7 g/dl ); coagulopathy; significant medical disorder(example, active liver disease, cardiovascular disease, renal failure, chronic adrenal failure, disorders requiring corticosteroid therapy); rupture of membrane and vaginitis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Complete abortion rate at 24 and 48 hours. Timepoint: every 6 hours. Method of measurement: Questioneaire.

Secondary

MeasureTime frame
Failure rate. Timepoint: No abortions occurred in 48 hours. Method of measurement: sonography.;Side effects of drug. Timepoint: Every 6 hours. Method of measurement: Questionnaire.;Induction abortion interval from insertion of first dose of misoprostol. Timepoint: Every 6 hours. Method of measurement: hour.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNayereh Rahmati

Mahdieh Hospital

n136054@yahoo.com+98 21 5506 6263

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026